Vai al contenuto principale
Foto gruppo

"Methodology"

Metodologia

Componenti

Fotografia

Settore ERC

LS7_7 - Pharmacology and toxicology

Attività

L'obiettivo è creare nuove conoscenze e sviluppare strumenti in un'ampia gamma di aree metodologiche rilevanti per il processo decisionale e la scienza regolatoria. Queste aree comprendono la biostatistica, la metodologia degli studi clinici, la modellazione e la simulazione, la farmacocinetica su base fisiologica (PBPK), la farmacologia quantitativa dei sistemi e la Real World Evidence.

  1. Farmacologia dei Sistemi Quantitativa

 

  1. Modellizzazione e Simulazione

European Medicine Agency (EMA)

Agenzia Italiana del Farmaco (AIFA)

EMA - Methodology Working Party

 

The aims are to create new knowledge and develop tools in a wide range of methodological areas that are relevant to decision making and regulatory science. These areas include biostatistics, clinical trial methodology, modelling & simulation, physiologically based pharmacokinetics (PBPK), quantitative systems pharmacology, and Real World Evidence.

  1. Quantitative System Pharmacology
  2. Modelling & Simulation

European Medicine Agency (EMA)
Agenzia Italiana del Farmaco (AIFA)

EMA - Methodology Working Party

Prodotti della ricerca

Farmacologia dei Sistemi Quantitativa / Quantitative System Pharmacology


Articoli / Articles

  • Rosa AC, Benetti E, Gallicchio M, Boscaro V, Cangemi L, Dianzani C, Miglio G. Analyzing Cysteine Site Neighbors in Proteins to Reveal Dimethyl Fumarate Targets. Proteomics 2019 Feb;19(4):e1800301. doi: 10.1002/pmic.201800301.
  • Miglio G. Analysis of fumarate-sensitive proteins and sites by exploiting residue interaction networks. Amino Acids 2018 May ;50(5):647-652. doi: 10.1007/s00726-018-2548-0.
  • Miglio G, Sabatino AD, Veglia E, Giraudo MT, Beccuti M, Cordero F. A computational analysis of S-(2-succino)cysteine sites in proteins. Biochim Biophys Acta 2016 Feb;1864(2):211-8. doi: 10.1016/j.bbapap.2015.11.003.

Abstract / Abstracts

  • Rosa A.C., Miglio G. Analysis of residue interaction networks to improve prediction of protein succination. British Pharmacological Society - Pharmacology 2017.
  • Ferrara B., Miglio G. Analysis of Topological Features for the Prioritization of Protein Succination. 38° Congresso Nazionale della Società Italiana di Farmacologia, 2017.
  • Rosa A.C., Benetti E., Audisio J., Miglio G. Targets of dimethyl fumarate: a novel predictive method based on concepts of network theory and machine learning. 39° Congresso Nazionale della Società Italiana di Farmacologia, 2019.
  • Miglio G., Romanò A., Sabatino A., Cordero F., Beccuti M., Giraudo M.T., Veglia E., Fantozzi R. The Mode of Action of Dimethyl Fumarate: Protein Succination and Anti-Pyroptotic Effects. pA2 Online 2014.

Tesi / Thesis

  • Alessandra Romanò. The mode of action of fumaric acid esters: protein succination and anti-pyroptotic effects. Chimica e Tecnologua Farmaceutiche, AA 2013/1014.
  • Francesca Damiano. Analysis and prediction of succination sites in proteins. Farmacia, AA 2015/2016.
  • Carlotta Corgiat Loia. Functional S-(2-succinyl)cysteine sites in proteins: prediction through network analysis of interacting residues. Farmacia, AA 2015/2016.
  • Jessica Audisio. Prediction of cysteine reactivity toward either dimethylfumarate or fumarate combining concepts of network theory and machine learning. Farmacia, AA 2016/2017.

Modellizzazione e simulazione / Modelling & Simulation


Abstract / Abstracts

  • Basso L., Rosa A.C., Benetti E., Miglio G. Natalizumab dosing in multiple sclerosis: in silico assessment of dosing strategies. Pharmadvances 2021: 3; 215-216.

Tesi / Thesis

  • Poonam Naruka Kanwar. Assessment of gentamicin-based therapy in neonates through pharmacokinetic-pharmacodynamic simulation. Farmacia, AA 2017/2018.
  • Elena Vaj. Ampicillin for the treatment of neonatal bacterial infections: a pharmacometric assessment by stochastic simulations. Farmacia, AA 2017/2018.
  • Viviana Mina. Design and implementation of a clinical decision support system for the optimization of ampicillin and gentamicin-based therapies intended for infants. Farmacia, AA 2018/2019.
  • Miryam Deborah Zamaro. Interstudy variability in population pharmacokinetic models for vancomycin administered to neonates. Farmacia, AA 2018/2019.
  • Edoardo Pierobon. Natalizumab EID (Extended Interval Dosing): trial clinico simulato su base farmacometrica e analisi budget impact. Scuola di Specializzazione in Farmacia Ospedaliera, AA 2018/2019.
  • Serena Ruzza. Natalizumab for the treatment of multiple sclerosis: strategies for the optimization of dosage regimens. Farmacia, AA 2019/2020.

Ultimo aggiornamento: 11/05/2023 11:04
Location: https://www.dstf.unito.it/robots.html
Non cliccare qui!